Study pinpoints the miRNA that promotes hair follicle growth

A research team from North Carolina State University has discovered a microRNA, or miRNA, that could make hairs to grow again.

Study pinpoints the miRNA that promotes hair follicle growth
Image Credit: Plashing Vole. Shared under a Creative Commons license.

Called miR-218-5p, the miRNA plays a crucial role in controlling the route involved in the regeneration of hair follicles and could be a potential candidate for developing drugs in the days to come.

The health of dermal papillae (DP) cells governs the growth of hairs. These cells control the growth cycle of hair follicles. Present-day treatments meant for hair loss can be both ineffective and expensive, spanning from chemical treatments to invasive surgeries that fail to give the required result.

According to new hair loss research, hair follicles do not vanish where balding takes place, but they simply reduce in size. The follicles may recover if the DP cells are replenished at those thinning sites.

Now, researchers have cultured the DP cells separately (2D) and also in a 3D spheroid setting. The team was headed by Ke Cheng, Randall B. Terry, Jr. Distinguished Professor in Regenerative Medicine at the College of Veterinary Medicine in North Carolina State University (NC State) and professor in the NC State/UNC Joint Department of Biomedical Engineering.

A spheroid is a 3D structure of cells that effectively reproduces the natural microenvironment of a cell.

In a hair regeneration mouse model, Cheng observed that the hair regrew quickly on mice that were treated with 3D spheroid-cultured DP cells in a keratin scaffolding, 2D cultured DP cells, and Minoxidil—a commercial hair loss treatment.

In a trial that was conducted for 20 days, the researchers noted that mice that were treated with the 3D DP cells regained a hair coverage of 90% at 15 days.

The 3D cells in a keratin scaffold performed best, as the spheroid mimics the hair microenvironment and the keratin scaffold acts as an anchor to keep them at the site where they are needed. But we were also interested in how DP cells regulate the follicle growth process, so we looked at the exosomes, specifically, exosomal miRNAs from that microenvironment.”

Ke Cheng, Randall B. Terry, Jr. Distinguished Professor in Regenerative Medicine, North Carolina State University

Exosomes are essentially small sacs released by cells that play a crucial role in cellular interaction. These tiny sacs contain miRNAs.

MiRNAs can be described as tiny molecules that control the expression of genes. Along with his team, Cheng quantified miRNAs in exosomes extracted from both 2D and 3D DP cells. In exosomes derived from 3D DP cells, the team identified miR-218-5p, a miRNA that improves the molecular route that supports the growth of hair follicles.

The researchers observed that when miR-218-5p levels were increased, they promoted the growth of hair follicles. Similarly, when miR-218-5p levels were inhibited, they impaired the function of hair follicles.

Cell therapy with the 3D cells could be an effective treatment for baldness, but you have to grow, expand, preserve and inject those cells into the area. MiRNAs, on the other hand, can be utilized in small molecule-based drugs. So potentially you could create a cream or lotion that has a similar effect with many fewer problems. Future studies will focus on using just this miRNA to promote hair growth.”

Ke Cheng, Randall B. Terry, Jr. Distinguished Professor in Regenerative Medicine, North Carolina State University

Source:
Journal reference:

Hu, S., et al. (2020) Dermal exosomes containing miR-218-5p promote hair regeneration by regulating β-catenin signaling. Science Advances. doi.org/ 10.1126/sciadv.aba1685.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of AZoLifeSciences.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Study may Provide a Roadmap for Addressing Cytokine Storms in Severe COVID-19